FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Abbott's first-of-a-kind smartphone compatible heart monitor has been approved by for use in the US. Now with the FDA's blessing, the Confirm Rx Insertable Cardiac Monitor (ICM) can be used by US ...

The U.S. Food and Drug Administration (US FDA) has said patients using diabetes devices that rely on smartphones, sometimes fail to receive alerts critical for their health. Users of smartphone ...

The FDA cautions that patients are not receiving or hearing smartphone alerts even though they thought their linked diabetes ...

The FDA has issued a safety communication regarding the potential for missed alerts with diabetes devices due to software or hardware changes.

The FDA is advising users of diabetes devices that rely on smartphones to deliver safety alerts to regularly check their smartphone settings to make sure they're receiving alerts. The agency said ...

The FDA is working with diabetes-related medical device manufacturers to ensure that smartphone alert configurations of their devices are carefully evaluated prior to use by patients. The agency ...

The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone ...

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to missed critical alerts. Issues arise from software configuration ...

The FDA notice concerns continuous glucose monitors, insulin pumps, and automated insulin dosing systems that rely on a smartphone to deliver critical safety alerts. The agency has received ...